NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
![Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6" Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"](https://pbs.twimg.com/media/C9AAsJjWsAEiHz-.jpg)
Denmark in New York on Twitter: "#DKBIO17 is "a great opportunity for us to broaden our scope and look for investors.” - Thomas H. Pedersen, CEO, NMD Pharma… https://t.co/AUeO5JqgX6"
![NMD PHARMA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile NMD PHARMA's Competitors, Revenue, Number of Employees, Funding, Acquisitions & News - Owler Company Profile](https://image2.owler.com/12585472-1529457760025.png)